Parkinson’s disease (PD) is a progressive neurodegenerative disease with intraneuronal aggregation of alpha-synuclein, and characteristic motor and non-motor symptoms, affecting more than 6.2 million people globally1. This evidence concerns the gene SNCA and Parkinson disease.